Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction.

作者信息

Ge Qintao, Zhao Zhijie, Li Xiao, Yang Feixiang, Zhang Meng, Hao Zongyao, Liang Chaozhao, Meng Jialin

机构信息

Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, P. R. China.

Institute of Urology, Anhui Medical University, Hefei, P. R. China.

出版信息

Clin Transl Med. 2024 Jan;14(1):e1552. doi: 10.1002/ctm2.1552.

DOI:10.1002/ctm2.1552

PMID:38239097

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10797244/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a5/10797244/0802e4be9511/CTM2-14-e1552-g004.jpg

相似文献

[1]

Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction.

Clin Transl Med. 2024-1

[2]

How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer.

Prostate Cancer Prostatic Dis. 2021-9

[3]

Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer.

Front Immunol. 2022

[4]

Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.

J Pathol. 2021-10

[5]

The role of regulatory T cells in the pathogenesis and treatment of prostate cancer.

Life Sci. 2021-11-1

[6]

Aging (Albany NY). 2020-11-10

[7]

T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer.

Clin Cancer Res. 2020-7-1

[8]

Singling out the immune-suppressive TME in prostate cancer.

Nat Rev Urol. 2023-4

[9]

Immune response drives outcomes in prostate cancer: implications for immunotherapy.

Mol Oncol. 2021-5

[10]

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.

Clin Cancer Res. 2007-12-1

引用本文的文献

[1]

Integrating Spatial Multi-Omics and Machine Learning to Unravel the Role of PANoptosis in Bladder Cancer Prognosis and Immunotherapy Response.

Oncol Res. 2025-8-28

[2]

Single-cell and spatial atlas of glioblastoma heterogeneity: characterizing the + subtype and 's oncogenic role.

Front Immunol. 2025-7-25

[3]

Identification of a key smooth muscle cell subset driving ischemic cardiomyopathy progression through single-cell RNA sequencing.

Sci Rep. 2025-7-27

[4]

Mapping the immunological landscape and emerging immunotherapeutic strategies in cervical cancer: a comprehensive review.

Front Oncol. 2025-7-10

[5]

Integrative single-cell and spatial transcriptomics uncover ELK4-mediated mechanisms in + tumor cells driving gastric cancer progression, metabolic reprogramming, and immune evasion.

Front Immunol. 2025-7-4

[6]

Single-cell technologies and spatial transcriptomics: decoding immune low - response states in endometrial cancer.

Front Immunol. 2025-7-2

[7]

The role of ATF3 in precision medicine of brain arteriovenous malformation: based on endothelial cell proliferation.

Front Immunol. 2025-6-27

[8]

Integrated multi-omics analysis reveals the immunotherapeutic significance of tumor cells with high FN1 expression in ovarian cancer.

Front Mol Biosci. 2025-6-19

[9]

Single-cell RNA sequencing reveals the potential role of Postn(+) fibroblasts in promoting the progression of myocardial fibrosis after myocardial infarction.

Sci Rep. 2025-7-1

[10]

Epithelial cells with high TOP2A expression promote cervical cancer progression by regulating the transcription factor FOXM1.

Front Oncol. 2025-6-16

本文引用的文献

[1]

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation.

Cell Death Dis. 2022-11-18

[2]

Inherited TP53 Variants and Risk of Prostate Cancer.

Eur Urol. 2022-3

[3]

Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer.

Int J Mol Sci. 2021-10-14

[4]

Immune response drives outcomes in prostate cancer: implications for immunotherapy.

Mol Oncol. 2021-5

[5]

Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy.

Cell. 2019-11-14

[6]

Transforming Growth Factor-β Signaling in Immunity and Cancer.

Immunity. 2019-4-16

[7]

Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer.

Transl Oncol. 2018-10

[8]

Suppressive IL-17AFoxp3 and ex-Th17 IL-17AFoxp3 T cells are a source of tumour-associated T cells.

Nat Commun. 2017-3-14

[9]

Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer.

J Clin Oncol. 2016-10-31

[10]

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.

Cancer Cell. 2011-5-17

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献